Literature DB >> 21736516

Microangiopathy of the inner ear, deafness, and cochlear implantation in a patient with Susac syndrome.

Aline Gomes Bittencourt1, Andrea Felice Dos Santos, Maria Valeria Schmidt Goffi-Gomez, Kellen Kutscher, Robinson Koji Tsuji, Rubens De Brito, Ricardo Ferreira Bento.   

Abstract

CONCLUSION: The cochlear implant was beneficial as an attempt to restore hearing and improve communication abilities in this patient with profound sensorineural hearing loss secondary to Susac syndrome.
OBJECTIVE: To report the audiological outcomes of cochlear implantation (CI) in a young woman with Susac syndrome after a 6-month follow-up period. Susac syndrome is a rare disorder. It is clinically characterized by a typical triad of sensorineural deafness, encephalopathy, and visual defect, due to microangiopathy involving the brain, inner ear, and retina.
METHODS: This was a retrospective review of a case at a tertiary referral center. After diagnosis, the patient was evaluated by a multidisciplinary team and received a cochlear implant in her right ear.
RESULTS: The patient achieved 100% open-set sentence recognition in noise conditions and 92% monosyllable and 68% medial consonant recognition in quiet conditions after 6 months of implant use. She reported the use of the telephone 3 months after activation.

Entities:  

Mesh:

Year:  2011        PMID: 21736516     DOI: 10.3109/00016489.2011.593549

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

Review 1.  Characteristics of Susac syndrome: a review of all reported cases.

Authors:  Jan Dörr; Sarah Krautwald; Brigitte Wildemann; Sven Jarius; Marius Ringelstein; Thomas Duning; Orhan Aktas; Erich Bernd Ringelstein; Friedemann Paul; Ilka Kleffner
Journal:  Nat Rev Neurol       Date:  2013-04-30       Impact factor: 42.937

Review 2.  Scoping review of cochlear implantation in Susac's syndrome.

Authors:  Philip L Pérez; Andrew A McCall; Barry E Hirsch
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2021-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.